Hemispherx Biopharma Inc  HEB
What Does This Company Do?
Hemispherx Biopharma develops therapeutics products that use nucleic-acid technologies to treat viral diseases and certain cancers. The company's Ampligen technology may treat hepatitis B, hepatitis C, chronic fatigue, immune dysfunction syndrome, HIV, renal cell carcinoma, and malignant melanoma. In addition, Hemispherx Biopharma is also developing diagnostic products that may diagnose chronic-fatigue syndrome, as well as a drugs taken in oral form that may treat various viral diseases.
Address 1617 JFK Boulevard
Philadelphia, PA  19103
Phone 1 215 988-0080
Website http://www.hemispherx.net
Direct Investment No
Dividend Reinvestment No
Employees 39
Become a Morningstar Premium Member. Enjoy our analyst picks and buy-sell opinions on 3,800 stocks, funds and ETFs. Learn more.

© Copyright 2014 Morningstar, Inc. All rights reserved. Morningstar, the Morningstar logo, Morningstar.com, Morningstar Tools are either trademark or service marks of Morningstar, Inc.
Past performance is no guarantee of future results.
Returns will vary and shares may be worth more or less than their original cost when sold.